Chaime Orlev

Q: What is Chaime Orlev email address?

Email Chaime Orlev at chaimeorlev@yahoo.com and chaimeo@kamada.com. This email is the most updated Chaime Orlev email found in 2026.

Q: How to contact Chaime Orlev?

To contact Chaime Orlev send an email to chaimeorlev@yahoo.com or chaimeo@kamada.com. (updated on October 31, 2024)

CFO at KAMADA (NASDAQ: KMDA; TASE: KMDA.TA) | Israel

About Chaime Orlev

Chaime Orlev serves as the Chief Financial Officer (CFO) of Kamada (NASDAQ: KMDA; TASE: KMDA.TA), a vertically integrated global biopharmaceutical company specializing in specialty plasma-derived therapeutics. With annual sales ranging from $125M to $135M and impressive double-digit EBITDA margins, Kamada is at the forefront of innovation in the biopharmaceutical sector. In his role, Chaime has demonstrated exceptional leadership and strategic acumen, particularly highlighted by his orchestration of a significant $170M acquisition and integration of a portfolio comprising four FDA-approved plasma-derived hyper-immune commercial products. This strategic move not only expanded Kamada's product offerings but also reinforced its market position in a highly competitive industry.

Chaime's expertise extends beyond acquisitions; he is adept in international tax strategies, contract negotiation, and corporate finance, making him a multifaceted leader capable of navigating the complexities of the biopharmaceutical landscape. His strong analytical skills and detail-oriented approach enable him to develop robust business plans that align with Kamada's long-term strategic goals. Chaime is also committed to fostering a collaborative and diverse corporate culture, cultivating high-performing finance teams that drive operational excellence. His positive leadership style and interpersonal skills empower employees at all levels, ensuring that the organization remains agile and responsive to market dynamics. As Kamada continues to innovate and expand its therapeutic offerings, Chaime Orlev's financial stewardship will be instrumental in guiding the company toward sustained growth and success in the biopharmaceutical arena.

Chaime Orlev Work